These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32882353)

  • 1. Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure.
    Asferg CL; Andersen UB; Linneberg A; Hedley PL; Christiansen M; Goetze JP; Jeppesen JL
    Peptides; 2020 Dec; 134():170390. PubMed ID: 32882353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men.
    Asferg CL; Andersen UB; Linneberg A; Hedley PL; Christiansen M; Goetze JP; Jeppesen JL
    Heart; 2017 Jan; 103(2):154-158. PubMed ID: 27496822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increased B-type natriuretic peptide in the absence of a cardiac abnormality identifies those whose left ventricular mass will increase over time.
    Nadir MA; Gandy S; Ireland S; MacDonald T; Dow E; Houston G; Lang C; Struthers A
    JACC Heart Fail; 2015 Jan; 3(1):87-93. PubMed ID: 25454393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obese Hypertensive Men Have Lower Circulating Proatrial Natriuretic Peptide Concentrations Despite Greater Left Atrial Size.
    Asferg CL; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
    Am J Hypertens; 2018 May; 31(6):645-650. PubMed ID: 29471357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriateness of ventricular hypertrophy is important as a determinant of BNP but not of diastolic filling in untreated hypertensive patients.
    Goda A; Nakao S; Tsujino T; Otsuka M; Matsumoto M; Yoshida C; Naito Y; Lee-Kawabata M; Ohyanagi M; Masuyama T
    Hypertens Res; 2009 Oct; 32(10):916-9. PubMed ID: 19662018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients.
    Salustri A; Cerquetani E; Piccoli M; Pastena G; Posteraro A; Amici E; La Carrubba S; Bakir S; Al Mahmeed WA
    Cardiovasc Ultrasound; 2009 Oct; 7():49. PubMed ID: 19863802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin resistance in nondipper essential hypertensive patients.
    Anan F; Takahashi N; Ooie T; Yufu K; Saikawa T; Yoshimatsu H
    Hypertens Res; 2003 Sep; 26(9):669-76. PubMed ID: 14620920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload.
    Mottram PM; Haluska BA; Marwick TH
    Am Heart J; 2004 Aug; 148(2):365-70. PubMed ID: 15309010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of left ventricular mass/end-diastolic volume ratio by three-dimensional echocardiography on two-dimensional global longitudinal strain and diastolic function in native hypertensive patients.
    Lembo M; Santoro C; Sorrentino R; Trimarco B; Galderisi M; Esposito R
    J Hypertens; 2019 Oct; 37(10):2041-2047. PubMed ID: 31157744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
    Tapp RJ; Sharp A; Stanton AV; O'Brien E; Chaturvedi N; Poulter NR; Sever PS; Thom SA; Hughes AD; Mayet J;
    J Am Coll Cardiol; 2010 Apr; 55(17):1875-81. PubMed ID: 20413040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.
    Mottram PM; Leano R; Marwick TH
    Am J Cardiol; 2003 Dec; 92(12):1434-8. PubMed ID: 14675580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings.
    Mak GS; DeMaria A; Clopton P; Maisel AS
    Am Heart J; 2004 Nov; 148(5):895-902. PubMed ID: 15523324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.
    Taylor JA; Christenson RH; Rao K; Jorge M; Gottlieb SS
    Am Heart J; 2006 Dec; 152(6):1071-6. PubMed ID: 17161055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-Type Natriuretic Peptide Is Associated with Indices of Left Ventricular Dysfunction in Healthy Subjects from the General Population: The Akershus Cardiac Examination 1950 Study.
    Lyngbakken MN; Kvisvik B; Aagaard EN; Berge T; Pervez MO; Brynildsen J; Tveit A; Steine K; Røsjø H; Omland T
    Clin Chem; 2021 Jan; 67(1):204-215. PubMed ID: 33279958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography.
    Ito H; Ishii K; Iwakura K; Nakamura F; Nagano T; Takiuchi S
    Hypertens Res; 2009 Oct; 32(10):895-900. PubMed ID: 19680260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.
    Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
    Eur J Heart Fail; 2005 Jan; 7(1):75-9. PubMed ID: 15642535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial augmentation index associated with increase in B-type natriuretic peptide in patients with hypertension.
    Sakuragi S; Maruo T; Taniguchi M; Nagase S; Nakamura K; Kusano KF; Ohe T
    Int J Cardiol; 2008 Nov; 130(3):414-9. PubMed ID: 18177956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.